Our media relations efforts are designed to inform the public about the vital work taking place across our clinical trials network. By sharing stories about clinical trial results, scientific milestones, and investigator achievements, we highlight the real-world progress made possible through the collective efforts of researchers, trial participants, and the broader cancer community. More than…
Film Shares Lung Cancer Patient’s Story and Highlights Importance of Clinical Trials The Alliance for Clinical Trials in Oncology has released a film highlighting the critical role of participant involvement in advancing cancer research and improving care. Presented by the Union for International Cancer Control (UICC) and produced for the Alliance by BBC StoryWorks Commercial…
Research Staff Represent Alliance at International Research Conference Three research staff members recently represented the Alliance at the Annual National Council of University Research Administrators (NCURA), an international meeting held annually. At the August 2026 meeting in New York City, about 9,000 NCURA members gathered to learn the latest guidance on research administration best practices,…
Highlighting the importance of clinical trials to advance treatments and improve screenings for the 1 in 8 women who will develop breast cancer in their lifetime This World Breast Cancer Research Day, the Alliance for Clinical Trials in Oncology is highlighting the importance of clinical research in advancing better treatments and improving early detection to…
RadiCaL study results show adding bone-targeting radium-223 to cabozantinib does not improve symptomatic skeletal-related events, highlighting the value of current standard treatments to optimize bone health for patients with bone metastases. Results from the Alliance for Clinical Trials in Oncology’s Phase II RadiCaL trial (Alliance A031801), the first randomized study of a radiopharmaceutical in kidney…
The media relations efforts from Alliance staff and researchers are designed to alert the public about the vital work happening across our network. When we share stories about clinical trial results, scientific milestones, or investigator achievements, we are showcasing the real-world progress you help make possible. More than just news mentions, these media stories serve…
New trial evaluates whether post-transplant consolidation therapy with teclistamab can improve survival in patients with primary plasma cell leukemia The Alliance for Clinical Trials in Oncology today announced the activation of The QUANTUM Trial (Alliance A062401), a clinical study designed to test a novel, immune-targeting approach for patients newly diagnosed with primary plasma cell leukemia…
Nominations are due Friday, August 28 for the 2026 Richard L. Schilsky CALGB Achievement Award. This is your chance to identify and honor the “unsung heroes” of the Alliance. The Richard L. Schilsky Cancer and Leukemia Group B Achievement Award acknowledges the significant contributions of an individual to cooperative group research. As an organization, Alliance…